Botulinum Toxin Ups Physical, Mental Health in Hyperhidrosis

This article originally appeared here.
Share this content:
Botulinum Toxin Ups Physical, Mental Health in Hyperhidrosis
Botulinum Toxin Ups Physical, Mental Health in Hyperhidrosis

FRIDAY, Feb. 19, 2016 (HealthDay News) -- For patients with hyperhidrosis, botulinum toxin treatment is associated with significant improvements in mental and physical health, according to a study published online Feb. 15 in the Journal of Dermatology.

Alexander Shayesteh, from Umeå University in Sweden, and colleagues examined the symptoms of anxiety, depression, and hazardous alcohol consumption among patients with hyperhidrosis. They further examined whether treatment with botulinum toxin changed these effects. Questionnaires regarding hyperhidrosis and symptoms were administered to 114 patients (average age of onset, 13.4 years; 48 percent described heredity for hyperhidrosis).

The researchers found that two weeks after botulinum toxin treatment, patients with axillary and palmar hyperhidrosis had significant improvements regarding mean hyperhidrosis disease severity scale, visual analog scale 10-point scale, hospital anxiety and depression scale, short-form health survey-36, and sweat-related health problems. Participants had no significant changes in mean alcohol use disorder identification tests.

"Primary hyperhidrosis mainly impairs mental rather than physical aspects of life and also interferes with specific daily activities of the affected individuals," the authors write. "Despite this, our patients did not show signs of anxiety, depression, or hazardous alcohol consumption."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »